Position in ASND
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$21,729,350
+$15,332,150 QoQ
Shares Held
95,000
+216.7% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$2,577,600
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Affinity Asset Advisors, LLC holds $1,518,254,571 across 81 Biotechnology names. ASND ranks #25 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,284,926 | $108,152,221 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
1,675,000 | $97,401,250 | |
| 3 | ERAS |
Erasca, Inc.
|
5,350,000 | $86,563,000 | |
| 4 | INSM |
INSMED Inc
|
480,000 | $78,489,600 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
2,800,000 | $77,560,000 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $64,519,518 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
1,400,000 | $55,608,000 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
170,000 | $54,772,300 |
All Filings in ASND
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,729,350 | 95,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,397,200 | 30,000 | Shares | Sole | 2026-02-13 | |
| 2023-12-31 | $2,519,000 | 20,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,344,896 | 46,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,155,080 | 57,760 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $4,288,800 | 40,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,670,863 | 70,997 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,326,000 | 100,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,628,087 | 125,087 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,083,200 | 120,000 | Shares | Sole | 2022-05-13 | |
| 2021-09-30 | $5,723,694 | 35,910 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,631,000 | 20,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,577,600 | 20,000 | Shares | Sole | 2021-05-14 | |
| 2021-03-31 | $2,577,600 | 20,000 | Put | Sole | 2021-05-14 | |
| 2020-12-31 | $1,667,800 | 10,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||